Literature DB >> 26695141

SENP1 regulates hepatocyte growth factor-induced migration and epithelial-mesenchymal transition of hepatocellular carcinoma.

Wenwen Zhang1, Huiyan Sun2, Xuefeng Shi3, Hua Wang2, Chunping Cui2, Fengjun Xiao2, ChuTse Wu2,4, Xiaozhong Guo5, Lisheng Wang6,7.   

Abstract

The deregulation of HGF/c-Met signaling is implicated in epithelial-mesenchymal transition (EMT) and progress of hepatocellular carcinoma (HCC). However, the epigenetic mechanisms that HGF/c-Met regulates EMT and metastasis of HCC cells are less explored. In this study, we demonstrated that HCC cells express a high level of SUMO/sentrin-specific protease 1 (Senp1) which is induced by HGF/c-Met signals. Lentivirus-mediated small hairpin RNA (shRNA) transduction results in Senp1 silence in HCC cells. Senp1 silence reduces the HGF-induced proliferation and migration of HCC cells. Senp1 inhibition also induces HCC cell apoptosis and growth arrest. Furthermore, Senp1 knockdown inhibits epithelial-to-mesenchymal transition, with increase of E-cadherin and ZO-1 expression, decrease of fibronectin and N-cadherin expression. The EMT-related transcription factor Zeb1 was SUMO-modified and decreased in Senp1-silenced HCC cells. These results delineate that senp1 might play an important role in the regulation of HGF-induced invasion and migration of HCC cells.

Entities:  

Keywords:  EMT; HCC; Senp1; Zeb1

Mesh:

Substances:

Year:  2015        PMID: 26695141     DOI: 10.1007/s13277-015-4406-y

Source DB:  PubMed          Journal:  Tumour Biol        ISSN: 1010-4283


  22 in total

Review 1.  Role of desumoylation in the development of prostate cancer.

Authors:  Jinke Cheng; Tasneem Bawa; Peng Lee; Limin Gong; Edward T H Yeh
Journal:  Neoplasia       Date:  2006-08       Impact factor: 5.715

Review 2.  Modification in reverse: the SUMO proteases.

Authors:  Debaditya Mukhopadhyay; Mary Dasso
Journal:  Trends Biochem Sci       Date:  2007-05-17       Impact factor: 13.807

3.  SUMOylation alterations are associated with multidrug resistance in hepatocellular carcinoma.

Authors:  Yu Qin; Huijing Bao; Yi Pan; Meilin Yin; Yunde Liu; Shangwei Wu; Huikai Li
Journal:  Mol Med Rep       Date:  2014-01-02       Impact factor: 2.952

4.  SUMO-specific protease 1 promotes prostate cancer progression and metastasis.

Authors:  Q Wang; N Xia; T Li; Y Xu; Y Zou; Y Zuo; Q Fan; T Bawa-Khalfe; E T H Yeh; J Cheng
Journal:  Oncogene       Date:  2012-06-25       Impact factor: 9.867

5.  SENP1 inhibition induces apoptosis and growth arrest of multiple myeloma cells through modulation of NF-κB signaling.

Authors:  Jun Xu; Hui-Yan Sun; Feng-Jun Xiao; Hua Wang; Yang Yang; Lu Wang; Chun-Ji Gao; Zi-Kuan Guo; Chu-Tse Wu; Li-Sheng Wang
Journal:  Biochem Biophys Res Commun       Date:  2015-03-17       Impact factor: 3.575

Review 6.  Targeting the HGF/c-MET pathway in hepatocellular carcinoma.

Authors:  Lipika Goyal; Mandar D Muzumdar; Andrew X Zhu
Journal:  Clin Cancer Res       Date:  2013-02-06       Impact factor: 12.531

Review 7.  Transitions between epithelial and mesenchymal states: acquisition of malignant and stem cell traits.

Authors:  Kornelia Polyak; Robert A Weinberg
Journal:  Nat Rev Cancer       Date:  2009-03-05       Impact factor: 60.716

Review 8.  Function and regulation of SUMO proteases.

Authors:  Christopher M Hickey; Nicole R Wilson; Mark Hochstrasser
Journal:  Nat Rev Mol Cell Biol       Date:  2012-12       Impact factor: 94.444

9.  Inhibition of p53 deSUMOylation exacerbates puromycin aminonucleoside-induced apoptosis in podocytes.

Authors:  Lingyu Wang; Jingwei Zhu; Ming Fang; Tuaner Zhang; Hua Xie; Nan Wang; Nan Shen; Hui Guo; Bo Fu; Hongli Lin
Journal:  Int J Mol Sci       Date:  2014-11-18       Impact factor: 5.923

Review 10.  Crosstalk of Oncogenic Signaling Pathways during Epithelial-Mesenchymal Transition.

Authors:  Stephan Lindsey; Sigrid A Langhans
Journal:  Front Oncol       Date:  2014-12-11       Impact factor: 6.244

View more
  16 in total

1.  The significance of SUMOylation of angiogenic factors in cancer progression.

Authors:  Mei Wang; Xiaodong Jiang
Journal:  Cancer Biol Ther       Date:  2018-09-27       Impact factor: 4.742

2.  Downregulation of SENP1 inhibits cell proliferation, migration and promotes apoptosis in human glioma cells.

Authors:  Qiu-Sheng Zhang; Meng Zhang; Xian-Jian Huang; Xiao-Jia Liu; Wei-Ping Li
Journal:  Oncol Lett       Date:  2016-05-12       Impact factor: 2.967

3.  Small ubiquitin-like modifier/sentrin-specific peptidase 1 associates with chemotherapy and is a risk factor for poor prognosis of non-small cell lung cancer.

Authors:  Keyuan Liu; Jing Zhang; Hao Wang
Journal:  J Clin Lab Anal       Date:  2018-07-24       Impact factor: 2.352

4.  Akt Protein Kinase, miR-200/miR-182 Expression and Epithelial-Mesenchymal Transition Proteins in Hibernating Ground Squirrels.

Authors:  Yang-Ja Lee; Joshua D Bernstock; Dace Klimanis; John M Hallenbeck
Journal:  Front Mol Neurosci       Date:  2018-01-30       Impact factor: 5.639

5.  8u, a pro-apoptosis/cell cycle arrest compound, suppresses invasion and metastasis through HSP90α downregulating and PI3K/Akt inactivation in hepatocellular carcinoma cells.

Authors:  Ning Wang; Shaopeng Chen; Bin Zhang; Shangfu Li; Feng Jin; Dan Gao; Hongxia Liu; Yuyang Jiang
Journal:  Sci Rep       Date:  2018-01-10       Impact factor: 4.379

6.  Attenuation of MET-mediated migration and invasion in hepatocellular carcinoma cells by SOCS1.

Authors:  Yirui Gui; Md Gulam Musawwir Khan; Diwakar Bobbala; Claire Dubois; Sheela Ramanathan; Caroline Saucier; Subburaj Ilangumaran
Journal:  World J Gastroenterol       Date:  2017-09-28       Impact factor: 5.742

Review 7.  Signal Transducer and Activator of Transcription (STATs) Proteins in Cancer and Inflammation: Functions and Therapeutic Implication.

Authors:  Chin-Yap Loh; Aditya Arya; Ahmed Fadhil Naema; Won Fen Wong; Gautam Sethi; Chung Yeng Looi
Journal:  Front Oncol       Date:  2019-02-21       Impact factor: 6.244

8.  Evidence of Omics, Immune Infiltration, and Pharmacogenomic for SENP1 in the Pan-Cancer Cohort.

Authors:  Somayye Taghvaei; Farzaneh Sabouni; Zarrin Minuchehr
Journal:  Front Pharmacol       Date:  2021-07-01       Impact factor: 5.810

9.  KSP inhibitor SB743921 inhibits growth and induces apoptosis of breast cancer cells by regulating p53, Bcl-2, and DTL.

Authors:  Li Zhu; Fengjun Xiao; Yue Yu; Hua Wang; Min Fang; Yuefeng Yang; Huiyan Sun; Lisheng Wang; Yuan Sheng
Journal:  Anticancer Drugs       Date:  2016-10       Impact factor: 2.248

Review 10.  The post-translational modification, SUMOylation, and cancer (Review).

Authors:  Zhi-Jian Han; Yan-Hu Feng; Bao-Hong Gu; Yu-Min Li; Hao Chen
Journal:  Int J Oncol       Date:  2018-02-22       Impact factor: 5.650

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.